Human amnion epithelial cells repair established lung injury

Cell Transplantation

Volumn 22, Issue 8, 2013, Pages 1337-1349

  Vosdoganes, Patricia ^a   Wallace, Euan M ^a   Chan, Siow Teng ^a   Acharya, Rutu ^a   Moss, Tim J M ^a   Lim, Rebecca ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

Amnion epithelial cells; Bleomycin; Chronic lung disease; Fibrosis; Inflammation; Regenerative medicine

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; BLEOMYCIN; COLLAGEN; PLATELET DERIVED GROWTH FACTOR ALPHA RECEPTOR; PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR; TRANSFORMING GROWTH FACTOR BETA;

AMNION CELL; AMNION EPITHELIAL CELL; AMNION EPITHELIAL CELL TRANSPLANTATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CELL ACTIVATION; CELL PROLIFERATION; CELL REGENERATION; CELL TRANSPLANTATION; CONTROLLED STUDY; DRUG EXPOSURE; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; LEUKOCYTE; LUNG; LUNG FIBROBLAST; LUNG FIBROSIS; LUNG INJURY; LUNG PARENCHYMA; MOUSE; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SYNTHESIS;

MUS;

ACTINS; AMNION; ANIMALS; BLEOMYCIN; BODY WEIGHT; CELL PROLIFERATION; COCULTURE TECHNIQUES; COLLAGEN; CYTOKINES; EPITHELIAL CELLS; FEMALE; FIBROBLASTS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; INFLAMMATION; LUNG; LUNG INJURY; MATRIX METALLOPROTEINASES; MICE; MICE, INBRED C57BL; STAINING AND LABELING; SURVIVAL ANALYSIS; WOUND HEALING;

EID: 85047686710     PISSN: 09636897     EISSN: None     Source Type: Journal    
DOI: 10.3727/096368912X657657     Document Type: Article

References (49)

1. Akle, C. A.; Adinolfi, M.; Welsh, K. I.; Leibowitz, S.; McColl, I. Immunogenicity of human amniotic epithelial cells after transplantation into volunteers. Lancet 2(8254):1003-1005; 1981.
2. Bose, B. Burn wound dressing with human amniotic membrane. Ann. R. Coll. Surg. Engl. 61(6):444-447; 1979.
3. Bourke, S. J,Interstitial lung disease: Progress and problems. Postgrad. Med. J. 82(970):494-499; 2006.
4. Cargnoni, A.; Gibelli, L.; Tosini, A.; Signoroni, P. B.; Nassuato, C.; Arienti, D.; Lombardi, G.; Albertini, A.; Wengler, G. S.; Parolini, O. Transplantation of allogeneic and xenogeneic placenta-derived cells reduces bleomycininduced lung fibrosis. Cell Transplant. 18(4):405-422; 2009.
5. Cargnoni, A.; Ressel, L.; Rossi, D.; Poli, A.; Arienti, D.; Lombardi, G.; Parolini, O. Conditioned medium from amniotic mesenchymal tissue cells reduces progression of bleomycin-induced lung fibrosis. Cytotherapy 14(2):153- 161; 2011.
6. Cerny, L.; Torday, J. S.; Rehan, V. K,Prevention and treatment of bronchopulmonary dysplasia: Contemporary status and future outlook. Lung 186(2):75-89; 2008.
7. Diaz-Prado, S.; Muinos-Lopez, E.; Hermida-Gomez, T.; Rendal-Vazquez, M. E.; Fuentes-Boquete, I.; de Toro, F. J.; Blanco, F. J. Multilineage differentiation potential of cells isolated from the human amniotic membrane. J. Cell. Biochem. 111(4):846-857; 2010.
8. Dua, H. S.; Gomes, J. A.; King, A. J.; Maharajan, V. S. The amniotic membrane in ophthalmology. Surv. Ophthalmol. 49(1):51-77; 2004.
9. Dunsmore, S. E.; Martinez-Williams, C.; Goodman, R. A.; Rannels, D. E. Composition of extracellular matrix of type 2 pulmonary epithelial cells in primary culture. Am. J. Physiol. 269(6 Pt 1):L754-765; 1995.
10. Eickelberg, O.; Kohler, E.; Reichenberger, F.; Bertschin, S.; Woodtli, T.; Erne, P.; Perruchoud, A. P.; Roth, M. Extracellular matrix deposition by primary human lung fibroblasts in response to TGF-b1 and TGF-b3. Am. J. Physiol. 276(5 Pt 1):L814-L824; 1999.
11. Fahey, M. C.; Wallace, E. M. Stem cells: Research tools and clinical treatments. J. Paediatr. Child Health 47(9): 672-675; 2011.
12. Ferry, G.; Lonchampt, M.; Pennel, L.; de Nanteuil, G.; Canet, E.; Tucker, G. C. Activation of MMP-9 by neutrophil elastase in an in vivo model of acute lung injury. FEBS Lett. 402(2-3):111-115; 1997.
13. Franz, M. G.; Payne, W. G.; Xing, L.; Naidu, D. K.; Salas, R. E.; Marshall, V. S.; Trumpower, C. J.; Smith, C. A.; Steed, D. L.; Robson, M. C. The use of amnion-derived cellular cytokine solution to improve healing in acute and chronic wound models. Eplasty 8:e21; 2008.
14. Ganatra, M. A. Amniotic membrane in surgery. J. Pak. Med. Assoc. 53(1):29-32; 2003.
15. Homer, R. J.; Elias, J. A.; Lee, C. G.; Herzog, E. Modern concepts on the role of inflammation in pulmonary fibrosis. Arch. Pathol. Lab. Med. 135(6):780-788; 2011.
16. Hori, J.; Wang, M.; Kamiya, K.; Takahashi, H.; Sakuragawa, N. Immunological characteristics of amniotic epithelium. Cornea 25(10 Suppl 1):S53-58; 2006.
17. Ilancheran, S.; Michalska, A.; Peh, G.; Wallace, E. M.; Pera, M.; Manuelpillai, U. Stem cells derived from human fetal membranes display multilineage differentiation potential. Biol. Reprod. 77(3):577-588; 2007.
18. Izbicki, G.; Segel, M. J.; Christensen, T. G.; Conner, M. W.; Breuer, R. Time course of bleomycin-induced lung fibrosis. Int. J. Exp. Pathol. 83(3):111-119; 2002.
19. Kang, J. W.; Koo, H. C.; Hwang, S. Y.; Kang, S. K.; Ra, J. C.; Lee, M. H.; Park, Y. H. Immunomodulatory effects of human amniotic membrane-derived mesenchymal stem cells. J. Vet. Sci. 13(1):23-31; 2012.
20. Koslowski, R.; Seidel, D.; Kuhlisch, E.; Knoch, K. P. Evidence for the involvement of TGF-b and PDGF in the regulation of prolyl 4-hydroxylase and lysyloxidase in cultured rat lung fibroblasts. Exp. Toxicol. Pathol. 55(4): 257-264; 2003.
21. Lee, S. B.; Li, D. Q.; Tan, D. T.; Meller, D. C.; Tseng, S. C. Suppression of TGF-b signaling in both normal conjunctival fibroblasts and pterygial body fibroblasts by amniotic membrane. Curr. Eye Res. 20(4):325-334; 2000.
22. Lemjabbar, H.; Gosset, P.; Lechapt-Zalcman, E.; Franco Montoya, M. L.; Wallaert, B.; Harf, A.; Lafuma, C. Overexpression of alveolar macrophage gelatinase B (MMP-9) in patients with idiopathic pulmonary fibrosis: Effects of steroid and immunosuppressive treatment. Am. J. Respir. Cell Mol. Biol. 20(5):903-913; 1999.
23. Li, H.; Niederkorn, J. Y.; Neelam, S.; Mayhew, E.; Word, R. A.; McCulley, J. P.; Alizadeh, H. Immunosuppressive factors secreted by human amniotic epithelial cells. Invest. Ophthalmol. Vis. Sci. 46(3):900-907; 2005.
24. Li, W.; He, H.; Chen, Y. T.; Hayashida, Y.; Tseng, S. C. Reversal of myofibroblasts by amniotic membrane stromal extract. J. Cell. Physiol. 215(3):657-664; 2008.
25. Lossos, I. S.; Breuer, R.; Shriki, M.; Or, R. Peribronchial lymphocyte activation in bleomycin-induced lung injury. Life Sci. 63(13):1183-1193; 1998.
26. Manali, E. D.; Moschos, C.; Triantafillidou, C.; Kotanidou, A.; Psallidas, I.; Karabela, S. P.; Roussos, C.; Papiris, S.; Armaganidis, A.; Stathopoulos, G. T.; Maniatis, N. A. Static and dynamic mechanics of the murine lung after intratracheal bleomycin. BMC Pulm. Med. 11:33; 2011.
27. McDonald, C.; Siatskas, C.; Bernard, C. The emergence of amnion epithelial stem cells for the treatment of multiple sclerosis. Inflammation and Regeneration 31(3):257-269; 2011.
28. McIntosh, K.; Zvonic, S.; Garrett, S.; Mitchell, J. B.; Floyd, Z. E.; Hammill, L.; Kloster, A.; Di Halvorsen, Y.; Ting, J. P.; Storms, R. W.; Goh, B.; Kilroy, G.; Wu, X.; Gimble, J. M. The immunogenicity of human adipose-derived cells: Temporal changes in vitro. Stem Cells 24(5):1246-1253; 2006.
29. Miki, T.; Lehmann, T.; Cai, H.; Stolz, D. B.; Strom, S. C. Stem cell characteristics of amniotic epithelial cells. Stem Cells 23(10):1549-1559; 2005.
30. Miravitlles, M.; Anzueto, A. Insights into interventions in managing COPD patients: Lessons from the TORCH and UPLIFT studies. Int. J. Chron. Obstruct. Pulmon. Dis. 4: 185-201; 2009.
31. Moeller, A.; Ask, K.; Warburton, D.; Gauldie, J.; Kolb, M. The bleomycin animal model: A useful tool to investigate treatment options for idiopathic pulmonary fibrosis? Int. J. Biochem. Cell Biol. 40(3):362-382; 2008.
32. Moodley, Y.; Atienza, D.; Manuelpillai, U.; Samuel, C. S.; Tchongue, J.; Ilancheran, S.; Boyd, R.; Trounson, A. Human umbilical cord mesenchymal stem cells reduce fibrosis of bleomycin-induced lung injury. Am. J. Pathol. 175(1):303- 313; 2009.
33. Moodley, Y.; Ilancheran, S.; Samuel, C.; Vaghjiani, V.; Atienza, D.; Williams, E. D.; Jenkin, G.; Wallace, E.; Trounson, A.; Manuelpillai, U. Human amnion epithelial cell transplantation abrogates lung fibrosis and augments repair. Am. J. Respir. Crit. Care Med. 182(5):643-651; 2010.
34. Murphy, S. V.; Shiyun, S. C.; Tan, J. L.; Chan, S.; Jenkin, G.; Wallace, E. M.; Lim, R. Human amnion epithelial cells do not abrogate pulmonary fibrosis in mice with impaired macrophage function. Cell Transplant. 21(7):1477-1492; 2012.
35. Murphy, S.; Lim, R.; Dickinson, H.; Acharya, R.; Rosli, S.; Jenkin, G.; Wallace, E. Human amnion epithelial cells prevent bleomycin-induced lung injury and preserve lung function. Cell Transplant. 20(6):909-923; 2010.
36. Murphy, S.; Rosli, S.; Acharya, R.; Mathias, L.; Lim, R.; Wallace, E.; Jenkin, G. Amnion epithelial cell isolation and characterization for clinical use. Curr. Protoc. Stem Cell Biol. 13:1E.6.1-1E.6.25; 2010.
37. National Health and Medical Research Council of Australia. Australian code of practice for the care and use of animals for scientific purposes. Canberra, Australia: NH&MRC; 2004.
38. Parolini, O.; Alviano, F.; Bagnara, G. P.; Bilic, G.; Buhring, H. J.; Evangelista, M.; Hennerbichler, S.; Liu, B.; Magatti, M.; Mao, N.; Miki, T.; Marongiu, F.; Nakajima, H.; Nikaido, T.; Portmann-Lanz, C. B.; Sankar, V.; Soncini, M.; Stadler, G.; Surbek, D.; Takahashi, T. A.; Redl, H.; Sakuragawa, N.; Wolbank, S.; Zeisberger, S.; Zisch, A.; Strom, S. C. Concise review: Isolation and characterization of cells from human term placenta: Outcome of the first international Workshop on Placenta Derived Stem Cells. Stem Cells 26(2):300-311; 2008.
39. Potian, J. A.; Aviv, H.; Ponzio, N. M.; Harrison, J. S.; Rameshwar, P. Veto-like activity of mesenchymal stem cells: Functional discrimination between cellular responses to alloantigens and recall antigens. J. Immunol. 171(7):3426- 3434; 2003.
40. Salazar, K. D.; Lankford, S. M.; Brody, A. R. Mesenchymal stem cells produce Wnt isoforms and TGF-b1 that mediate proliferation and procollagen expression by lung fibroblasts. Am. J. Physiol. Lung Cell. Mol. Physiol. 297(5):L1002- L1011; 2009.
41. Schneider, T.; Osl, F.; Friess, T.; Stockinger, H.; Scheuer, W. V. Quantification of human Alu sequences by real-time PCR-an improved method to measure therapeutic efficacy of anti-metastatic drugs in human xenotransplants. Clin. Exp. Metastasis 19(7):571-582; 2002.
42. Schneider, T.; Osl, F.; Friess, T.; Stockinger, H.; Scheuer, W. V. Quantification of human Alu sequences by real-time PCR-an improved method to measure therapeutic efficacy of anti-metastatic drugs in human xenotransplants. Clin. Exp. Metastasis 19(7):571-582; 2002.
43. Tseng, S. C.; Li, D. Q.; Ma, X. Suppression of transforming growth factor-b isoforms, TGF-b receptor type 2, and myofibroblast differentiation in cultured human corneal and limbal fibroblasts by amniotic membrane matrix. J. Cell. Physiol. 179(3):325-335; 1999.
44. Vosdoganes, P.; Hodges, R. J.; Lim, R.; Westover, A. J.; Acharya, R. Y.; Wallace, E. M.; Moss, T. J. Human amnion epithelial cells as a treatment for inflammation-induced fetal lung injury in sheep. Am. J. Obstet. Gynecol. 205(156): 26-33; 2011.
45. World Health Organisation. World Health Statistics Geneva. http://www.who.int/whosis/whostat/2008/en/index.html. Accessed 20th June 2012.
46. Wolbank, S.; Peterbauer, A.; Fahrner, M.; Hennerbichler, S.; van Griensven, M.; Stadler, G.; Redl, H.; Gabriel, C. Dose-dependent immunomodulatory effect of human stem cells from amniotic membrane: A comparison with human mesenchymal stem cells from adipose tissue. Tissue Eng. 13(6):1173-1183; 2007.
47. Yao, P. M.; Delclaux, C.; d'Ortho, M. P.; Maitre, B.; Harf, A.; Lafuma, C. Cell-matrix interactions modulate 92-kD gelatinase expression by human bronchial epithelial cells. Am. J. Respir. Cell Mol. Biol. 18(6):813-822; 1998.
48. Zhang, X.; Ren, X.; Li, G.; Jiao, C.; Zhang, L.; Zhao, S.; Wang, J.; Han, Z. C.; Li, X. Mesenchymal stem cells ameliorate experimental autoimmune uveoretinitis by comprehensive modulation of systemic autoimmunity. Invest. Ophthalmol. Vis. Sci. 52(6):3143-3152; 2011.
49. Zhou, H. P.; Yi, D. H.; Yu, S. Q.; Sun, G. C.; Cui, Q.; Zhu, H. L.; Liu, J. C.; Zhang, J. Z.; Wu, T. J. Administration of donor-derived mesenchymal stem cells can prolong the survival of rat cardiac allograft. Transplant. Proc. 38(9): 3046-3051; 2006.